Epidemiology and Health

Brief Communication

Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011: Inmyung Song, Ju-Young Shin; Epidemiol Health. 2016;38:e2016045. Published online October 26, 2016; DOI: https://doi.org/10.4178/epih.e2016045

13,276 View
269 Download
14 Web of Science
15 Crossref

Abstract

OBJECTIVES
This study analyzed the prevalence of attention deficit hyperactivity disorder (ADHD) medication use among children and adolescents in Korea between January 1, 2007 and December 31, 2011.

METHODS

Using the Korea National Health Insurance claims database, we identified patients between one and 17 years of age who had at least one medical claim for the diagnosis of ADHD (International Classification of Diseases, 10th revision: F90.0). The annual prevalence of ADHD diagnoses was calculated, using national census data from Statistics Korea on the population aged between one and 17 years as the denominator. The prevalence was age-standardized using the 2010 population as the standard population. The number of patients who were treated with methylphenidate and/or atomoxetine and the prevalence of total patients with ADHD that were treated with either drug were also calculated for each year. All analyses were stratified according to gender and age group (1-5 years, 6-12 years, and 13-17 years).

RESULTS

The number of patients diagnosed with ADHD increased from 72,704 persons (0.71%) in 2007 to 85,468 persons (0.93%) in 2011. The annual age-standardized prevalence of ADHD diagnoses increased from 0.67% in 2007 to 0.94% in 2011. The prevalence of methylphenidate use among children and adolescents with ADHD decreased from 73.91% in 2007 to 70.33% in 2011, whereas that of atomoxetine use increased from 5.77% in 2009 to 13.09% in 2011.

CONCLUSIONS

While methylphenidate remains the most commonly prescribed ADHD drug, the use of atomoxetine has increased.

Summary

Korean summary
전국민보험자료를 분석한 본 연구에 따르면 한국의 17세 이하 소아인구에서 주의력결핍과다행동장애(ADHD) 진단을 받은 환자의 비율이 2007년 0.71%에서 2011년 0.93%로 증가하였다. ADHD 진단받은 환자 중 메틸페니데이트를 처방받은 환자 비율은 2007년 73.91%에서 2011년 70.33%로 감소한 반면, 아토목세틴을 처방받은 환자 비율을 2009년 5.77%에서 2011년 13.09%로 증가하였다

Citations

Citations to this article as recorded by

Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia
Kentaro Kawabe, Fumie Horiuchi, Yu Matsumoto, Saori Inoue, Maya Okazawa, Rie Hosokawa, Kiwamu Nakachi, Junya Soga, Shu‐Ichi Ueno
Neuropsychopharmacology Reports.2024; 44(1): 29. CrossRef
Association between children with attention-deficit hyperactivity disorder and parental mental health: Data from the 2011–2020 Korea National Health and Nutrition Examination Survey
Woolim Ko, Hyunsuk Jeong
Journal of Affective Disorders.2024; 350: 544. CrossRef
Investigating Variations in Medicine Approvals for Attention-Deficit/Hyperactivity Disorder: A Cross-Country Document Analysis Comparing Drug Labeling
Laila Tanana, Asam Latif, Prasad S Nishtala, Timothy F Chen
Journal of Attention Disorders.2024;[Epub] CrossRef
Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea
Yoon Cho, Ah-Young Kim, Sukhyang Lee, Hankil Lee
International Clinical Psychopharmacology.2024;[Epub] CrossRef
Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
Jae Heon Kim, Suyeon Park, Yeon Jung Lee
Journal of the Korean Academy of Child and Adolescent Psychiatry.2023; 34(2): 125. CrossRef
Minnesota Multiphasic Personality Inventory‐Adolescent‐Restructured Form (MMPI‐A‐RF) characteristics of ADHD in a Korean psychiatric sample
Cheryl Chakranarayan, Nathan C. Weed, Kyunghee Han, Reid L. Skeel, Kyungjoo Moon, Ji‐Hae Kim
Journal of Clinical Psychology.2022; 78(5): 913. CrossRef
Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016
Laila Tanana, Christopher Harrison, Prasad S. Nishtala, Timothy F. Chen
European Neuropsychopharmacology.2022; 65: 68. CrossRef
Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Luise Kazda, Katy Bell, Rae Thomas, Kevin McGeechan, Rebecca Sims, Alexandra Barratt
JAMA Network Open.2021; 4(4): e215335. CrossRef
Drug Prescriptions for Children With ADHD in Japan: A Study Based on Health Insurance Claims Data Between 2005 and 2015
Makiko Yoshida, Taku Obara, Saya Kikuchi, Michihiro Satoh, Yoshihiko Morikawa, Nobuhiro Ooba, Hiroaki Yamaguchi, Nariyasu Mano
Journal of Attention Disorders.2020; 24(2): 175. CrossRef
Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change
Eonjeong Kim, Susin Park, Yewon Kim, Nam Kyung Je
International Clinical Psychopharmacology.2020; 35(6): 329. CrossRef
The female side of pharmacotherapy for ADHD—A systematic literature review
Francien M. Kok, Yvonne Groen, Anselm B. M. Fuermaier, Oliver Tucha, Gerard Hutchinson
PLOS ONE.2020; 15(9): e0239257. CrossRef
Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data
Daniele Piovani, Antonio Clavenna, Maurizio Bonati
European Journal of Clinical Pharmacology.2019; 75(10): 1333. CrossRef
The Symptom Trajectory of Attention-Deficit Hyperactivity Disorder in Korean School-Age Children
Kyoung Min Kim, Mina Ha, Myung Ho Lim, Ho-Jang Kwon, Seung-Jin Yoo, Eunjung Kim, Ki Chung Paik
Psychiatry Investigation.2018; 15(5): 470. CrossRef
Parental smoking and depression, and attention‐deficit hyperactivity disorder in children and adolescents: Korean national health and nutrition examination survey 2005‐2014
Youn Joo Cho, Ran Choi, Susan Park, Jin‐won Kwon
Asia-Pacific Psychiatry.2018;[Epub] CrossRef
Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives
Karen S. Rommelfanger, Sung-Jin Jeong, Arisa Ema, Tamami Fukushi, Kiyoto Kasai, Khara M. Ramos, Arleen Salles, Ilina Singh, Jordan Amadio, Guo-Qiang Bi, Paul Frederick Boshears, Adrian Carter, Anna Devor, Kenji Doya, Hermann Garden, Judy Illes, L. Syd M.
Neuron.2018; 100(1): 19. CrossRef

First
Prev
Page of 1
Next
Last

Search